April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Efficacy & Complications Of ExPress Mini Shunt Surgery For Uncontrolled Glaucoma
Author Affiliations & Notes
  • George C. Papachristou
    Ophthalmology, Penn State Hershey Eye Center, Hershey, Pennsylvania
  • Ali Aminlari
    Ophthalmology, Penn State Hershey Eye Center, Hershey, Pennsylvania
  • Wenxin Wei
    Ophthalmology, University of California, Irvine, California
  • Footnotes
    Commercial Relationships  George C. Papachristou, None; Ali Aminlari, None; Wenxin Wei, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2635. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      George C. Papachristou, Ali Aminlari, Wenxin Wei; Efficacy & Complications Of ExPress Mini Shunt Surgery For Uncontrolled Glaucoma. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2635.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the efficacy and complications of ExPress Mini Shunt for surgical treatment of glaucoma.

Methods: : Retrospective, chart review of 45 patients undergoing ExPress Mini Shunt glaucoma procedure for treatment of uncontrolled glaucoma, between May, 2009 - October, 2010. All procedures were performed by a single surgeon (AA). The study included patients with glaucoma, undergoing ExPress Mini Shunt surgery alone or combined with cataract extraction. Intraocular pressure (IOP), visual acuity, glaucoma medications, and complications were recorded preoperatively, and postoperatively at 1 day, 1 week, 1 month, 2 months, 4 months, 6 months and 1 year. Similar to the Tube Vs Trabeculectomy (TVT) study shunt failure was defined as; IOP>21mHg, or not reduce by 20% from the baseline on consecutive visits after 3 months, IOP <5 mmHg on consecutive visits, re-operation for glaucoma or loss of light perception.

Results: : Forty-five patients and 49 cases were included in the study. Average age at surgery was 69.84(±18.22), with the majority being female (63.27%;n=31) Vs male (36.74%;n=18). The majority of eyes were pseudophakic (57.14%;n=28). Etiology of glaucoma was chronic open angle glaucoma (42.86%;n=21), neovascular (16.33%;n=8), pseudoexfoliation (10.20%;n=5), combined mechanism (10.20%;n=5), inflammatory (4.08%;n=2), congenital (4.08%;n=2), aphakic (4.08%;n=2), low tension glaucoma (2.04%;n=1), post penetrating keratoplasty (2.04%;n=1), steroid induced (2.04%;n=1), pigment dispersion syndrome (2.04%;n=1). Mean IOP at the preoperative visit, post-operative visit day 1, week 1, month 1, month 2, month 4, month 6, and 1 year was 26.78±9.54, 10.54±5.71, 16.59±8.9, 18.67±7.39, 18.85±9.35, 18.29±10.54, 12.82±4.58, 13.89±4.26 respectively. Average glaucoma medication usage at the preoperative visit, post-operative visit day 1, week 1, month 1, month 2, month 4, month 6, and 1 year was 3.84, 0.41±1.15, 0.16±0.52, 0.31±0.87, 0.74±1.24, 1.14±1.42, 1.38±1.89, 1.09±1.51, 0.89±1.17 respectively. The rate of ExPress Mini shunt failure was 18.52%. Postoperative complications developed in 20 (40.82%) patients, with choroidals being most common (n=14;28.57%).

Conclusions: : Express Mini shunt insertion achieved a statistically significant reduction in IOP at the 1 year post operative (0.015) visit, while conferring a statistically significant decrease in medication use. The rate of failure was similar to studies evaluating trabeculectomies to other shunts, though the study is limited by a small sample size and short follow up to date.

Keywords: intraocular pressure • clinical (human) or epidemiologic studies: outcomes/complications 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×